StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Methyl iodide → 2-Chloro-5-(methylsulphonyl)benzoic acid

HRID 32665
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 32665
[Cl:1][C:2]1[CH:10]=[CH:9][C:8]([S:11]([OH:13])=[O:12])=[CH:7][C:3]=1[C:4]([OH:6])=[O:5].[OH-].[Na+].[CH3:16]I>CO.O>[Cl:1][C:2]1[CH:10]=[CH:9][C:8]([S:11]([CH3:16])(=[O:13])=[O:12])=[CH:7][C:3]=1[C:4]([OH:6])=[O:5]
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

6

Edukt 3

HCID 6328Methyl iodideHCID 14798Sodium Hydroxide2×HCID 151129042-Chloro-5-sulfino-benzoic acid

Produkt 1

HCID 23291322-Chloro-5-(methylsulphonyl)benzoic acid

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 887MethanolLösungsmittelHCID 962
Water
Lösungsmittel

Versuchsvorschrift

A mixture of 1 g (4 mmol)2-Chloro-5-sulfino-benzoic acid in 20 ml Methanol and 20 ml water was treated with 10N NaOH to pH=9 before adding 1.7 g (12 mmol) Methyliodide. The mixture was heated for 48 h to 80° C. with occasional addition of NaOH to maintain pH=9. After removal of all volatiles HCl conc. was added and the mixture was extracted with ethyl acetate. The combined organic layers were dried with MgSO4 and evaporated to dryness. The residue was taken up in methanol and subjected to reversed phase HPLC purification eluting with an acetonitrile/water gradient to yield after evaporation of the product fractions 323 mg (34%) of the title compound. MS (m/e): 233.0 (MH−, 100%).

Aufarbeitung

  1. temperatureto maintain pH=9
  2. customAfter removal of all volatiles HCl conc.
  3. additionwas added
  4. extractionthe mixture was extracted with ethyl acetate
  5. dry with materialThe combined organic layers were dried with MgSO4
  6. customevaporated to dryness
  7. customsubjected to reversed phase HPLC purification
  8. washeluting with an acetonitrile/water gradient
  9. customto yield
  10. customafter evaporation of the product fractions 323 mg (34%) of the title compound

Quellen und Nachweise

ORD-Eintrag
ord-411be09c46464de888fffbac19646277
Quelldatensatz
uspto-grants-2008_09
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US07427612B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion